Capricor Therapeutics CAPR Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $27.38M+44.7% | $23.13M+58.9% | $20.36M+72.4% | $22.05M+76.3% | $18.92M+70.4% | ||
| $9.4M+54.9% | $6.02M+41.0% | $5.92M+71.1% | $5.67M+85.5% | $6.07M+49.0% | ||
| $36.77M+47.2% | $29.16M+54.9% | $26.28M+72.1% | $27.72M+78.1% | $24.98M+64.7% | ||
| $36.77M+47.2% | $29.16M+54.9% | $26.28M+72.1% | $27.72M+78.1% | $24.98M+64.7% | ||
| -$36.77M-47.2% | -$29.16M-279% | -$26.28M-102% | -$27.72M-139% | -$24.98M-143% | ||
| $2.9M+298% | $2.02M+194% | $1.71M+278% | $1.79M+203% | $729.54K+54.6% | ||
| $2.83M+379% | —— | $1.71M+278% | $1.81M+206% | $591.35K+25.3% | ||
| -$81.14K+46.1% | —— | -$6.85K+75.7% | —— | -$150.67K-434% | ||
| -$33.94M-39.2% | —— | —— | —— | -$24.39M-141% | ||
| $0— | —— | —— | —— | $0-100% | ||
| -$33.94M-39.2% | -$30.17M-324% | -$24.57M-95.7% | -$25.91M-136% | -$24.39M-149% | ||
| -$0.59-11.3% | -$0.62-464% | -$0.54-42.1% | -$0.57-62.9% | -$0.53-71.0% | ||
| -$0.59-11.3% | -$0.62-464% | -$0.54-42.1% | -$0.57-62.9% | -$0.53-71.0% | ||
| 57.4M+25.9% | 46.5M+32.0% | 45.7M+38.2% | 45.7M+43.5% | 45.6M+45.5% | ||
| 57.4M+25.9% | 46.5M+32.0% | 45.7M+38.2% | 45.7M+43.5% | 45.6M+45.5% | ||
| $2.9M+298% | $2.02M+194% | $1.71M+278% | $1.79M+203% | $729.54K+54.6% | ||
| -$34.48M-46.1% | -$30.73M-397% | -$25.11M-99.1% | -$26.34M-136% | -$23.61M-143% | ||
| -$536.88K-168% | -$560.97K-160% | -$543.45K-825% | -$424.35K-178% | $784.97K+992% | ||
| $8.15K-34.8% | $11.21K+500% | $6.74K+261% | $14.99K+703% | $12.49K+568% | ||
| -$36.77M-47.2% | -$29.16M-279% | -$26.28M-102% | -$27.72M-139% | -$24.98M-143% | ||
| -$36.24M-47.4% | -$28.65M-291% | -$25.79M-104% | -$27.23M-142% | -$24.58M-147% | ||
| -$36.24M-47.4% | -$28.65M-291% | -$25.79M-104% | -$27.23M-142% | -$24.58M-147% | ||
| -$36.77M-47.2% | -$29.16M-279% | -$26.28M-102% | -$27.72M-139% | -$24.98M-143% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's income statement data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.